Asia Pacific Pharmaceutical Continuous Manufacturing Market to Grow at a CAGR of 10.5% to reach US$ 604.91 Million from 2020 to 2027
Asia Pacific, the pharmaceutical continuous manufacturing market, is anticipated to reach US$ 604.91 Mn in 2027 from US$ 274.10 Mn in 2019. The market is projected to grow with a CAGR of 10.5% from 2020-2027.
The pharmaceutical continuous manufacturing market is growing primarily due to the advantages offered by continuous manufacturing process. Restraining factor such as, low R&D funding by government in developing economies is likely to damage the growth of the market in the coming years. On the other hand, emerging markets is expected to have a positive impact on the growth of the Asia Pacific pharmaceutical continuous manufacturing market in the coming years.
Countries in Asia Pacific and South and Central America are emerging as attractive outsourcing locations for biopharmaceutical industries. Low manufacturing and operating costs in China and India are key factors driving the growth of pharmaceutical manufacturing market in the region. Recent growth in the biopharmaceutical industry in both China and India indicates positive future outlook for the market. Moreover, the growing domestic Asia Pacific pharmaceutical continuous manufacturing market and its pipelines are further opening up new avenues for the contract manufacturers as well as generic drug manufacturing in the APAC.
China’s pipeline has shown rapid growth in recent years. According to the International Society for Pharmaceutical Engineering, in 2016, the China Food and Drug Administration (CFDA) registered around 200 new biological pharmaceuticals entering clinical trials. Continuous pharmaceutical manufacturing is expected to contribute to the overall industry’s growth, and mostly benefit early-stage drug innovators owing to error-free development procedure. Moreover, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities, further boosting the growth of the market. For instance, In January 2020, STA Pharmaceutical Co., Ltd., – a subsidiary of WuXi AppTec opened a new large-scale oligonucleotide active pharmaceutical ingredient (API) manufacturing facility in China. Thus, the emerging markets are likely to act as high potential growth and revenue generators in the pharmaceutical continuous manufacturing market.
Considering the geographic and economical operations between Asian countries and China, the countries are expected to witness the challenge of COVID-19. The outbreak of disease has severely affected the tourism industry, lead to supply chain disruptions and problems posed by the shortage of healthcare infrastructure in low-income countries. For preventing the spread of disease, restrictive measures have been taken in South Korea, Malaysia, Singapore, the Philippines, and India. COVID-19 outbreak is expected to have short- and long-term impacts in the region. Domestic startups backed by international funding have already started witnessing back out from investors putting the development of the products in jeopardy.
In 2019, the Japan accounted for the largest market share in Asia Pacific pharmaceutical continuous manufacturing market, and it is also expected to grow at a faster pace over the forecast period. Growing aging population, increase the demand for advanced manufacturing capabilities, and increased the number of new drug approvals are the key factors that are responsible for the highest revenue share of the region. Moreover, the government is focusing on easing the regulatory policies and thereby accelerating the development and approval of new drugs into the market. Hence, considering the mentioned factors, the pharmaceutical continuous manufacturing market is expected to grow at a significant pace in the US during the forecast period.
Rest of Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
ASIA PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING – MARKET SEGMENTATION
By Product
- Integrated Systems
- Semi-Continuous Systems
- Continuous Granulators
- Continuous Blenders
- Continuous Compressors
- Continuous Coaters
- Continuous Dryers
- Other Semi-Continuous Systems
- Controls
By Application
- End Product Manufacturing
- Solid Dosage Manufacturing
- Liquid Dosage Manufacturing
- API Manufacturing
By End-User
- Full Scale Manufacturing Companies
- Pharmaceutical Companies
- Contract Manufacturing Organizations
- R & D Departments
- Contract Research Organizations
- Research Institutes
By Geography
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
Company Profiles
- Powrex Corp
- ACG
- Cadmach Machinery Co. Pvt. Ltd
- Hosokawa Micron Group,
- THERMO FISHER SCIENTIFIC INC.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Pharmaceutical Continuous Manufacturing Market – By Product
1.3.2 Asia Pacific Pharmaceutical Continuous Manufacturing Market – By Application
1.3.3 Asia Pacific Pharmaceutical Continuous Manufacturing Market – By End User
1.3.4 Asia Pacific Pharmaceutical Continuous Manufacturing Market – By Country
2. Asia Pacific Pharmaceutical Continuous Manufacturing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Pharmaceutical Continuous Manufacturing Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific Pharmaceutical Continuous Manufacturing Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Pharmaceutical Continuous Manufacturing - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Advantages Offered by Continuous Manufacturing Process
5.2 Key Restraints
5.2.1 Low R&D Funding by Government in Developing Economies
5.3 Key Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trend
5.4.1 Increasing Adoption of Continuous Manufacturing in Pharmaceuticals
5.5 Impact Analysis
6. Pharmaceutical Continuous Manufacturing Market – Asia Pacific Analysis
6.1 Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue Forecasts and Analysis
7. Pharmaceutical Continuous Manufacturing Market Analysis – By Product
7.1 Overview
7.2 Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
7.3 Integrated Systems
7.3.1 Overview
7.3.2 Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4 Semi-Continuous Systems
7.4.1 Overview
7.4.2 Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.3 Continuous Granulators
7.4.3.1 Overview
7.4.3.2 Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.4 Continuous Blenders
7.4.4.1 Overview
7.4.4.2 Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.5 Continuous Compressors
7.4.5.1 Overview
7.4.5.2 Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.6 Continuous Coaters
7.4.6.1 Overview
7.4.6.2 Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.7 Continuous Dryers
7.4.7.1 Overview
7.4.7.2 Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.4.8 Other Semi-Continuous Systems
7.4.8.1 Overview
7.4.8.2 Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
7.5 Controls
7.5.1 Overview
7.5.2 Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
8. Pharmaceutical Continuous Manufacturing Market– By Application
8.1 Overview
8.2 Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
8.3 End Product Manufacturing
8.3.1 Overview
8.3.2 End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.3.3 Solid Dosage Manufacturing
8.3.3.1 Overview
8.3.3.2 Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.3.4 Liquid Dosage Manufacturing
8.3.4.1 Overview
8.3.4.2 Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
8.4 API Manufacturing
8.4.1 Overview
8.4.2 API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9. Pharmaceutical Continuous Manufacturing Market – By End User
9.1 Overview
9.2 Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
9.3 Full-Scale Manufacturing Companies
9.3.1 Overview
9.3.2 Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.3.3 Pharmaceutical Companies
9.3.3.1 Overview
9.3.3.2 Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.3.4 Contract Manufacturing Organizations
9.3.4.1 Overview
9.3.4.2 Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4 R&D Departments
9.4.1 Overview
9.4.2 R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4.3 Contract Research Organizations
9.4.3.1 Overview
9.4.3.2 Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
9.4.4 Research Institutes
9.4.4.1 Overview
9.4.4.2 Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
10. Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.2.1 Asia Pacific: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.3 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.3.1 Asia Pacific: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.4 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.4.1 Asia Pacific: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.4.2 Asia Pacific: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.5 Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Country, 2018 & 2027 (%)
10.1.6 China: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.6.1 China: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.6.1.1 China: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.6.2 China: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.6.2.1 China: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.6.3 China: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.6.3.1 China: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.6.3.2 China: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.7 Japan: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Japan: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.7.1.1 Japan: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.7.2 Japan: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.7.2.1 Japan: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.7.3 Japan: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.7.3.1 Japan: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.7.3.2 Japan: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.8 India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 India: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.8.2.1 India: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.8.3 India: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.8.3.1 India: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.8.4 India: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.8.4.1 India: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.8.4.2 India: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.9 South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 South Korea: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.9.2.1 South Korea: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.9.3 South Korea: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.9.3.1 South Korea: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.9.4 South Korea: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.9.4.1 South Korea: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.9.4.2 South Korea: R&D Departments Market, by Type, 2018–2027 (USD Million)
10.1.10 Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.1 Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
10.1.10.2 Australia: Pharmaceutical Continuous Manufacturing Market, by Product, 2018–2027 (USD Million)
10.1.10.2.1 Australia: Semi-Continuous Systems Market, by Type, 2018–2027 (USD Million)
10.1.10.3 Australia: Pharmaceutical Continuous Manufacturing Market, by Application, 2018–2027 (USD Million)
10.1.10.3.1 Australia: End Product Manufacturing Market, by Type, 2018–2027 (USD Million)
10.1.10.4 Australia: Pharmaceutical Continuous Manufacturing Market, by End User, 2018–2027 (USD Million)
10.1.10.4.1 Australia: Full-Scale Manufacturing Companies Market, by Type, 2018–2027 (USD Million)
10.1.10.4.2 Australia: R&D Departments Market, by Type, 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Pharmaceutical Continuous Manufacturing Market
11.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Powrex Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 ACG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Cadmach Machinery Co. Pvt. Ltd.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Hosokawa Micron Group
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 THERMO FISHER SCIENTIFIC INC.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 5. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 6. Asia Pacific: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. Asia Pacific: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. China: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 9. China: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 10. China: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. China: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. China: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. China: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. China: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Japan: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 16. Japan: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 17. Japan: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 18. Japan: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 19. Japan: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 20. Japan: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 21. Japan: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 22. India: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 23. India: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 24. India: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. India: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. India: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 27. India: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 28. India: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. South Korea: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 30. South Korea: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 33. South Korea: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. South Korea: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 35. South Korea: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Australia: Pharmaceutical Continuous Manufacturing Market, by Product– Revenue and Forecast to 2027 (USD Million)
Table 37. Australia: Semi-Continuous Systems Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 38. Australia: Pharmaceutical Continuous Manufacturing Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 39. Australia: End Product Manufacturing Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 40. Australia: Pharmaceutical Continuous Manufacturing Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 41. Australia: Full-Scale Manufacturing Companies Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 42. Australia: R&D Departments Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 43. Glossary of Terms, Asia Pacific Pharmaceutical Continuous Manufacturing Market
LIST OF FIGURES
Figure 1. Pharmaceutical Continuous Manufacturing Market Segmentation
Figure 2. Asia Pacific Pharmaceutical Continuous Manufacturing Market Overview
Figure 3. The Integrated Systems Segment Held Largest Share of Product Segment in Pharmaceutical Continuous Manufacturing Market
Figure 4. Japan Is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market- Leading Country Markets (US$ Mn)
Figure 6. Asia Pacific Pharmaceutical Continuous Manufacturing Market - Asia Pacific PEST Analysis
Figure 7. Pharmaceutical Continuous Manufacturing Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Pharmaceutical Continuous Manufacturing Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Pharmaceutical Continuous Manufacturing Market Share, by Product, 2019 and 2027 (%)
Figure 10. Integrated Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 11. Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 12. Continuous Granulators: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 13. Continuous Blenders: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 14. Continuous Compressors: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 15. Continuous Coaters: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 16. Continuous Dryers: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 17. Other Semi-Continuous Systems: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 18. Controls: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ Million)
Figure 19. Pharmaceutical Continuous Manufacturing Market Share, by Application, 2019 and 2027 (%)
Figure 20. End Product Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Solid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 22. Liquid Dosage Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 23. API Manufacturing: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 24. Pharmaceutical Continuous Manufacturing Market Share, by End User, 2019 and 2027 (%)
Figure 25. Full-Scale Manufacturing Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Pharmaceutical Companies: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 27. Contract Manufacturing Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 28. R&D Departments: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Contract Research Organizations: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 30. Research Institutes: Pharmaceutical Continuous Manufacturing Market– Revenue and Forecast to 2027 (US$ million)
Figure 31. Asia Pacific: Pharmaceutical Continuous Manufacturing Market, by Key Country – Revenue (2019) (USD Million)
Figure 32. Asia Pacific Pharmaceutical Continuous Manufacturing Market Revenue and Forecast to 2027 (USD Million)
Figure 33. China: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. Japan: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. India: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. South Korea: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Australia: Pharmaceutical Continuous Manufacturing Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
- Powrex Corp
- ACG
- Cadmach Machinery Co. Pvt. Ltd
- Hosokawa Micron Group,
- THERMO FISHER SCIENTIFIC INC.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For